Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?

Laliscia, Concetta; Delishaj, Durim; Fabrini, Maria Grazia; Gonnelli, Alessandra; Morganti, Riccardo; Perrone, Franco; Tana, Roberta; Paiar, Fabiola; Gadducci, Angiolo

Laliscia, Concetta; Delishaj, Durim; Fabrini, Maria Grazia; Gonnelli, Alessandra; Morganti, Riccardo; Perrone, Franco; Tana, Roberta; Paiar, Fabiola; Gadducci, Angiolo.

Afiliación

Laliscia C; Department of Translational Medicine, Division of Radiation Oncology.
Delishaj D; Department of Translational Medicine, Division of Radiation Oncology.
Fabrini MG; Department of Translational Medicine, Division of Radiation Oncology.
Gonnelli A; Department of Translational Medicine, Division of Radiation Oncology.
Morganti R; Department of Experimental and Clinical Medicine, Section of Statistics.
Perrone F; Department of Translational Medicine, U.O Fisica Sanitaria.
Tana R; Department of Experimental and Clinical Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
Paiar F; Department of Translational Medicine, Division of Radiation Oncology.
Gadducci A; Department of Experimental and Clinical Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.

J Contemp Brachytherapy ; 8(6): 512-517, 2016 Dec.

Article en En | MEDLINE | ID: mdl-28115957

Palabras clave

HDR vaginal brachytherapy; endometrial cancer; hyaluronic acid

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: J Contemp Brachytherapy Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google